FRANKLIN, Tenn., May 25, 2010 (GLOBE NEWSWIRE) -- BioMimetic Therapeutics, Inc. (Nasdaq:BMTI) announced today that Dr. Samuel E. Lynch, president and CEO, will provide an update of corporate activities at the INVEST Tennessee Equity Conference on Thursday, May, 27th at 10:15 a.m. CDT. The presentation will be held in the HL Room of the Nashville Convention Center in Nashville, Tenn.
